Previous Article | Next Article ![]()
Infection and Immunity, July 2000, p. 4289-4296, Vol. 68, No. 7
Departments of
Pediatrics1 and Internal
Medicine,2 Division of Pulmonary and Critical
Care Medicine, The University of Michigan Medical School, Ann
Arbor, Michigan 48109-0360
Received 20 December 1999/Returned for modification 15 February
2000/Accepted 24 March 2000
Pulmonary infection due to Pseudomonas aeruginosa has
emerged as a leading cause of mortality. A vigorous host response is required to effectively clear the organisms from the lungs. This host
defense is dependent on the recruitment and activation of neutrophils
and macrophages. A family of chemotactic cytokines (chemokines) has
been shown to participate in this protective response. In this study,
we assessed the role of the ELR+ (glutamic
acid-leucine-arginine motif positive) CXC chemokines and their CXC
chemokine receptor (CXCR2) in lung antibacterial host defense. The
intratracheal administration of Pseudomonas to mice
resulted in the time-dependent influx of neutrophils to the lung,
peaking at 12 to 24 h after inoculation. The influx of
neutrophils was associated with a similar time-dependent expression of
the ELR+ CXC chemokines, KC, macrophage inflammatory
protein 2 (MIP-2), and lipopolysaccharide-induced CXC chemokine (LIX).
Selective neutralization of MIP-2 or KC resulted in modest changes in
neutrophil influx but no change in bacterial clearance or survival.
However, neutralization of CXCR2 resulted in a striking increase in
mortality, which was associated with a marked decrease in neutrophil
recruitment and bacterial clearance. Conversely, the site-specific
transgenic expression of KC resulted in enhanced clearance of bacteria
after Pseudomonas challenge. This study indicates that
ELR+ CXC chemokines are critical mediators of
neutrophil-mediated host defense in Pseudomonas pneumonia.
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
CXC Chemokine Receptor CXCR2 Is Essential for Protective Innate
Host Response in Murine Pseudomonas aeruginosa
Pneumonia
*
Corresponding author. Mailing address: The University
of Michigan Medical Center, Departments of Pediatrics and Internal
Medicine, Division of Pulmonary and Critical Care Medicine, 6301 MSRBIII, Box 0642, Ann Arbor, MI 48109-0642. Phone: (734) 764-4554. Fax: (734) 764-4556. E-mail: wctsai{at}umich.edu.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|